Cited Publications

Valve-in-valve hemodynamics of 20-mm transcatheter aortic valves in small bioprostheses

Transcatheter aortic valve (TAV) implantation is a treatment for selected patients with failing bioprostheses. We previously showed that currently available SAPIEN (Edwards Lifesciences, Irvine, CA) TAV sizes did not yield acceptable valve-in-valve (VIV) hemodynamics in small degenerated bioprostheses because optimal TAV function requires full stent expansion to its nominal size.

Go to the Article


Sign up for our newsletter today

Website Survey

Answer a few questions about our website and we'll enter you into draw for a limited edition KENEK EDGE Pulse Oximeter.

Prizes will be shipped to 5 North American survey respondents that include their email contact information.

Take Survey No Thanks